Provided by Tiger Trade Technology Pte. Ltd.

Global X HealthTech ETF

29.72
+0.80682.79%
Volume:2K
Turnover:66.94K
Market Cap:31.20M
PE:- -
High:29.72
Open:29.09
Low:29.09
Close:28.91
52wk High:33.41
52wk Low:23.00
Shares:1.05M
Float Shares:1.05M
Volume Ratio:0.74
T/O Rate:0.22%
Dividend:0.07
Dividend Rate:0.24%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Oscar Health call volume above normal and directionally bullish

TIPRANKS
·
1 hour ago

Moderately bullish activity in Hims and Hers Health with shares up 7.5%

TIPRANKS
·
1 hour ago

MedTech Growth Concerns Likely to Overshadow Q3 Results, Leerink Says

Reuters
·
Yesterday

MedPal AI Sets October General Meeting as It Advances AI-Driven Health Platform

TIPRANKS
·
Yesterday

Medibank names digital health expert for board ahead of 2026 AGM

TIPRANKS
·
Yesterday

Gartner Inc. Stock Climbs 5.2%, Outperforms Peers

Dow Jones
·
Yesterday

Cboe data shows mixed options sentiment in Hims and Hers Health with shares down 4.89%

TIPRANKS
·
Yesterday

Oscar Health (OSCR) Draws Undervalued Calls, Is The Huge Fair Value Gap Credible?

Simply Wall St.
·
Yesterday

Olorofim vs. AmBisome: A Phase III Antifungal Trial With Implications for IQVIA Holdings (IQV)

TIPRANKS
·
Yesterday

Citi Reaffirms Two Top Medtech Picks: Bullish on Abbott's Business Recovery and DexCom's Market Share Gains

Deep News
·
Oct 08

Barclays Initiates Coverage on 26 U.S. Medical Technology Stocks as Valuations Hit Decade Low, Top Picks Include Stryker and Abbott

Stock News
·
Oct 08

IQVIA Launches Explorer for Commercial Decision-Making

MT Newswires Live
·
Oct 08

Iqvia launches Iqvia Explorer

TIPRANKS
·
Oct 08

Iqvia Launches Iqvia Life Science Models to Help Life Sciences Companies Predict Clinical Trial Outcomes

Reuters
·
Oct 08

Hims & Hers Names Jon Franklin as Chief Accounting Officer

THOMSON REUTERS
·
Oct 08

Hims & Hers Names Jonathan Franklin Principal Accounting Officer as Irene Becklund Resigns Role

Reuters
·
Oct 08

Oscar Health call volume above normal and directionally bullish

TIPRANKS
·
Oct 08

Moderna, Merck Climb on Collaboration with Tempus

Reuters
·
Oct 08

Should Type 2 Care Report Require Action From DexCom (DXCM) Investors?

Simply Wall St.
·
Oct 07

Tempus AI announces multi-year collaboration with Moderna, Merck

TIPRANKS
·
Oct 07